[
Genetics
|
Automated External Defibrillators
|
Returned Drugs
|
Regulation of Distressed Devices
|
Science Teaching
]
GENETICS
TMA worked to ensure no legislation in the
78th legislative session would preclude authentic medical
scientific research. In concert with the geneticists in the state
as well as the medical academic institutions, TMA provided
revised language and definitions in House Bill 3521 and HB 1175,
in particular "human cloning," "human embryo," and "somatic cell
nuclear transfer" and sought to educate the members of the
legislature regarding scientific research in genetics. The topic
will be included in the TMA scientific symposia planned during
the interim.
HB 3521, authored by Rep. Ken Paxton
(R-McKinney), would have made it a felony to conduct destructive
research on a human embryo with the exceptions of in vitro
fertilization and accompanying transfer of a human embryo to a
woman's body or a diagnostic procedure that may benefit a human
embryo that is subjected to the procedure. Advocates for the bill
viewed destructive research as part of the abortion issue. The
bill was left pending.
HB 1175, authored by Rep. Phil King
(R-Weatherford), would have banned human cloning and made it a
felony to intentionally engage in human cloning. The bill also
would have imposed a civil penalty of not less than $5 million or
more than $10 million for each violation. Although the intent was
to impact human cloning activities specifically, the bill's
original language would have precluded much scientific research.
The bill was left pending.
Senate Bill 1284, authored by Mario
Gallegos (D-Houston), would have authorized the Texas Department
of Health (TDH) to purchase tandem mass spectrometers for newborn
genetic screening and to hire employees to use the machines. The
March of Dimes was a major force behind the bill in an attempt to
further its national initiative to have 10 specific screening
tests performed on all newborns. However, in 2002 the TMA Council
on Scientific Affairs had been in discussion with TDH and had
outlined in writing concerns associated with implementing tandem
mass spectrometry in the state at this time. Although sympathetic
to the arguments to test for the additional illnesses, TMA's
concerns about the clinical, operational, and financial issues of
the existing newborn genetic screening program outweighed adding
new tests. The bill was left pending.
AUTOMATED EXTERNAL DEFIBRILLATORS
HB 965 by Rep. Ken Mercer (R-San Antonio)
would have required TDH, in consultation with the Texas Education
Agency, to study the cost and feasibility of installing automated
external defibrillators in public high school buildings. The bill
required the estimation of the extent of improvement in the
survival rate of those individuals experiencing sudden cardiac
arrest while in a public high school, costs of personnel,
maintenance, training, and other factors. TMA's Committee on
Cardiovascular Diseases opposed the bill due to the significant
cost for a very low potential savings of lives per year. The
committee proposed that a better idea would be to require
coaches, band directors, and other appropriate personnel to be
trained in cardiopulmonary resuscitation (CPR). The American
Heart Association project to train all high school sophomores in
CPR in health class discovered that coaches often are not
trained. The bill was left pending.
RETURNED DRUGS
HB 3486, authored by Rep. Diane Delisi
(R-Temple), permits the return of certain unused drugs from a
health care facility to a pharmacy and reimbursement for those
returned drugs under the state's medical assistance program. No
controlled substance may be returned. The unused drugs must be
(1) approved by the federal Food and Drug Administration (FDA),
(2) sealed in the original unopened tamper-evident packaging and
either individually packaged or packaged in unit-dose packaging,
(3) oral or parenteral medications in sealed single-dose
containers approved by the FDA, (4) topical or inhalant drugs in
sealed units-of-use containers approved by the FDA, (5)
parenteral medications in sealed multiple-dose containers from
which doses have not been withdrawn, and (6) not be the subject
of a mandatory recall by a state or federal agency or a voluntary
recall by a drug seller or manufacturer. The following drugs may
not be returned: compounded, appears on inspection to be
adulterated, requires refrigeration, or has less than 120 days
until the expiration date or end of the shelf life.
The pharmacy may restock and redistribute
these returned unused drugs and shall reimburse or credit the
state Medicaid program for the returned drugs. The health care
facility will be required to inform the Health and Human Services
Commission (HHSC) of drugs returned to a pharmacy. A lengthy
listing of prohibited acts are included in the bill, covering
misbranding/adulteration, dissemination of any false
advertisement, failure to maintain records or make required
reports, counterfeiting trademarks/trade names/imprints, and
more. HHSC is required to adopt rules governing the determination
of the amount of reimbursement or credit for restocking drugs. A
HIPAA-compliant electronic system for issuing credit for returned
drugs will be provided. Only those drugs for which the credit
exceeds the cost of the restocking fee by at least 100 percent
are eligible for credit. Also, a task force will be established
to develop the rules. The task force must include representatives
of nursing facilities and pharmacies.
TMA supported the intent to have a
realistic, reasonable process for cost-savings. The governor
signed the bill on June 18 and it was effective immediately. HB
2292 (see above) also allows for reuse of returned drugs as
described in HB 3486.
REGULATION OF DISTRESSED DEVICES
SB 1392, authored by Sen. Kyle Janek, MD,
(R-Houston), would have created an exception to the existing law
requiring medical device salvagers to restore distressed devices
and equipment to full working order before offering them for
resale and return to use. The pertinent regulations no longer
would have applied to licensed equipment salvagers selling
equipment to hospitals, whether public, private, or state-owned,
or to hospitals selling to or trading equipment with other
hospitals. Instead, the seller would have had to disclose the
condition of the equipment/device to the buyer in concise, dated
written statements containing the transferring entity's name, a
description of the device's condition, and the following
statement: "Prior to use, a distressed device that does not meet
the manufacturer's specifications must be reconditioned." TMA's
Council on Scientific Affairs' (CSA) initial concern regarding
this deregulation was resolved with intensive research into the
topic and discussions with the Texas Hospital Association. The
bill was left pending.
SCIENCE TEACHING
HB 411 by Rep. Kent Grusendorf
(R-Arlington) and Sen. Rodney Ellis (D-Houston) requires
establishing master science teacher certifications for
elementary, middle, and high school grade levels. The prescribed
course of instruction is to be developed in consultation with
science faculty members at institutions of higher education. Also
included is a grant program to encourage teachers to become
certified, funds for paying stipends to certified teachers who
teach at high-need campuses, and provisions for providing
training materials and other resources for teachers. Grade 8 was
added to the grade levels at which students will be assessed in
science. The option of implementing an after-school program or
summer program to provide science education was also in the bill.
The governor signed the bill on June 20, and it is effective
Sept. 1.
Based on its sponsorship of the TMA
Excellence in Science Teaching Awards Program, CSA supported this
bill in theory as enhancing science teaching in Texas schools.
The hesitancy regarding the fiscal note was resolved when it was
noted that federal funds would be used for implementation.
Medical science TMA staff
contacts:
-Barbara James, RN, director,
Science and Quality Department, (512) 370-1400
-C.J. Francisco, JD, senior counsel, Office of the
General Counsel, (512) 370-1339
-Yvonne Barton, associate director, Legislative Affairs
Department, (512) 370-1359
|
[
Overview
|
Professional Liability Reform
|
Patient Safety/Quality Improvement
|
Managed Care/Insurance Reform
|
Health Care Funding
|
Health and Human Services
Reorganization
|
Scope of Practice
|
Public Health
|
Rural Health
|
Mental Health
|
Workers' Compensation
|
Tax Reform
|
Long-Term Care
|
Workforce/Medical Education
|
Abortion and Related Legislation
|
Health Facility Regulation
|
Transplantation/Organ Donation
]